Neurocrine Biosciences
NBIX
#1519
Rank
S$15.11 B
Marketcap
$151.56
Share price
-0.74%
Change (1 day)
-18.59%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): S$0.68 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.35 Billion. , an increase over its 2023 earnings that were of S$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 S$0.68 B64.57%
2023 S$0.41 B41.13%
2022 S$0.29 B73.74%
2021 S$0.17 B-8.82%
2020 S$0.18 B77.78%
2019 S$0.10 B49.83%
2018 S$70.14 M-142.57%
2017 -S$0.17 Billion-14.73%
2016 -S$0.2 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$86.27 Million29.66%
2013 -S$66.54 Million-3530.8%
2012 S$1.93 M-95.73%
2011 S$45.43 M
2009 -S$63.87 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.29 Billion87.3%
2006 -S$0.16 Billion351.97%
2005 -S$33.59 Million-52.09%
2004 -S$70.1 Million-10.98%
2003 -S$78.74 Million
2001 -S$58.78 Million
1999 -S$26.51 Million108.32%
1998 -S$12.73 Million
1996 S$3.88 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$25.74 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.08 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$36.08 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.98 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.97 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.88 B 2,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$29.75 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$55.94 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA